To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Kalderos nets $28m Series B
Chicago-based Kalderos, a provider of drug discount management solutions, has secured $28 million in Series B funding.
